Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 7.4%.
- Date of event: 22 Oct 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 7.4% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 22 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 7.4% | 339,633 | 0 | 339,633 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 7.4% | 339,633 | 0 | 339,633 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 7.4% | 339,633 | 0 | 339,633 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |